logo

Astrazeneca bonuses




astrazeneca bonuses

2 Zapopan, Jal.
The rebellion at AstraZeneca comes after investors in turnaround specialist Melrose staged one of the largest revolts this year, triggered by disgruntlement over a decision to pay a 42m bonus to each of four directors.
More than a third of Unilever investors registered opposition to its pay plans earlier this month, while Persimmon experienced a revolt against the grossly excessive 75m bonus handed to its chief executive, Jeff Fairburn.
Graham Chipchase, the chairman of the remuneration committee, replied saying the company was mindful of a public debate over high executive pay and the board had to support its managers through a turnaround phase, started by Soriot in 2012.Shares in, astraZeneca dropped on Friday best slot game for ipad vegas after it revealed a 46 drop in operating profits for the first quarter, with play free slot machine with bonus games yahoo earnings tumbling to 896m, which was much worse than feared by City analysts.1 Tuxtla Gutiérrez, Chis.To continue reading this article, start your free trial of Premium.Access all Premium articles, subscriber-only events, cancel any time.Crestor, as well as higher costs.The payout was ultimately approved because nearly a third of shareholders abstained and of those who voted,.5 cast in favour and.5 against.Opposition from more than 60 of voting investors forced shreveport poker rooms Inmarsat to rip up its pay proposals, continuing a long-running dispute that had broken out into rebellion three times in the past six years.
Earlier this month, the advisory group International Shareholder Services advised investors that.9m bonus for the chief executive was not suitably aligned with performance, while another group, Pirc, advised shareholders to vote against the pay report, arguing that targets set by the remuneration committee.




The rebellion opposed.4m pay package for chief executive Pascal Soriot, even though this was a drop from.3m a year earlier, when the company suffered votes against its pay policy and warnings from shareholder advisory groups over its bonus plans.1 Ciudad Victoria, Tamps.Pascal Soriot, chief executive of AstraZeneca.Nearly 26 of, melrose shareholders who voted at its annual meeting earlier this month failed to back its pay report, with leading City institution and top 20 shareholder Standard Life Aberdeen among the rebels.5 Mérida, Yuc.AstraZeneca has been rocked by one of the biggest shareholder revolts over executive pay this year, after more than a third of investors failed to back the pharmaceutical companys remuneration report.
Mr Soriot's base salary increased from.17m in 2015.19m in 2016, according to the pharmaceutical company's annual report.
Free for 30 days then only 2 per week, try Premium, register for free to continue reading this article.


Sitemap